Commentary: Exploratory research on therapeutic agents combined with early diagnostic biomarkers for colorectal cancer
Jingui Wan, Yuannan Lu, Ying Dai, Meixia Ye · 2026
Read Commentary: Exploratory research on therapeutic agents combined with early diagnostic biomarkers for colorectal cancer by Jingui Wan, Yuannan Lu, Ying Dai, Meixia Ye (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13196287.txt.
Description
Jingui Wan and co-authors write, in a 2026 note, on a study that paired gene marks of colon cancer fate with a drug found by computer. Liao's team merged two big sets, TCGA and GEO, and drew 15 genes whose shift tied to life span. Dock sums and dish tests then backed one drug, SB-225002, as a new-use hope. The note backs the joined path: fate marks and drug hunts in one run. Yet one gap stands, they argue. No cause link ties the drug to the gene set.
The drug is known as a CXCR2 block, which works on the tumor's ground. Dock sums hint it may touch the mark genes straight. Which tale is true is not yet shown.
Catalog record
| CREATOR | Jingui Wan, Yuannan Lu, Ying Dai, Meixia Ye |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 8 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |